Chargement en cours...

Understanding and circumventing resistance to anticancer monoclonal antibodies

With the widespread use of therapeutic monoclonal antibodies in the treatment of patients with cancer, resistance to these agents has become a major issue. Preclinical models of drug action or resistance have contributed to unravel the main mechanisms of resistance, involving both tumor-associated a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Reslan, Lina, Dalle, Stéphane, Dumontet, Charles
Format: Artigo
Langue:Inglês
Publié: Landes Bioscience 2009
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2726592/
https://ncbi.nlm.nih.gov/pubmed/20065642
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!